Tinghao J. Li
Chongqing, 400016, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
TRIM59 Drives Bladder Cancer Progression Through E3 Ligase-Dependent K48-Linked Degradation of PTRF.
TRIM59 Drives Bladder Cancer Progression Through E3 Ligase-Dependent K48-Linked Degradation of PTRF.
Journal: Cancer science
Published: February 09, 2026
RBM11 drives malignant progression of bladder cancer by regulating GNPDA1-PKM2 axis.
Journal: iScience
Published: December 29, 2025
Single-cell transcriptome analysis reveals DNMT1+ epithelial cells promote lymphatic metastasis via CXCL17-mediated TAM infiltration.
Journal: Journal of translational medicine
Published: November 22, 2025
The FN1-ITGB4 Axis Drives Acquired Chemoresistance in Bladder Cancer by Activating FAK Signaling.
Journal: Oncology research
Published: August 19, 2025
Transglutaminase 2 facilitates metastasis of basal-like bladder cancer by sustaining MVP-mediated MAPK/ERK1/2 signaling activation.
Journal: Cancer letters
Published: July 27, 2025
Cancer-associated fibroblast derived CXCL14 drives cisplatin chemoresistance by enhancing nucleotide excision repair in bladder cancer.
Journal: Journal of experimental & clinical cancer research : CR
Published: April 21, 2025
Identification of multicohort-based predictive signature for NMIBC recurrence reveals SDCBP as a novel oncogene in bladder cancer.
Journal: Annals of medicine
Published: January 28, 2025
Nucleolar protein 3 promotes proliferation of bladder cancer cells through the PI3K-Akt pathway.
Journal: World journal of surgical oncology
Published: October 19, 2024
Comprehensive analysis of RNA methylation-related genes to identify molecular cluster for predicting prognosis and immune profiles in bladder cancer.
Journal: Scientific reports
Published: May 28, 2024
Last Updated: 09/26/2026